Oncothyreon (ONTY) Reports License Agreement With Array (ARRY) for ONT-380
Tweet Send to a Friend
Oncothyreon Inc. (Nasdaq: ONTY) today announced that Array BioPharma Inc. (Nasdaq: ARRY) has granted Oncothyreon an exclusive license to develop ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
